Noradrenergic circuit mechanisms of persistent fear

持续恐惧的去甲肾上腺素能回路机制

• 批准号: 9223120
• 负责人: Roger L Clem
• 金额: $ 4.21万
• 依托单位: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-12-15 至 2019-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9223120
• 关键词: Adaptive Behaviors; Address; Adrenergic Agents; Adrenergic Receptor; Adverse effects; Affect; American; Amygdaloid structure; Animals; Anxiety; Area; Attenuated; Auditory; Behavior; Behavioral; Brain; Brain region; Cells; Coupled; Cues; Data; Disease; Disease remission; Electrophysiology (science); Elements; Emotional; Emotions; Event; Exposure to; Extinction (Psychology); Failure; Food; Fright; G-substrate; GTP-Binding Proteins; Goals; Hippocampus (Brain); Hyperactive behavior; Impairment; In Vitro; Individual; Interneurons; Laboratories; Learning; Medial; Mediating; Memory; Metabolic; Military Personnel; Modeling; Modification; Mus; Nature; Neuromodulator; Neuronal Plasticity; Neurons; Neurotransmitters; Norepinephrine; Outcome; Panic; Parvalbumins; Pathway interactions; Pharmacology; Phobias; Post-Traumatic Stress Disorders; Prefrontal Cortex; Process; Psychological reinforcement; RNA; Receptor Cell; Receptor Signaling; Recovery; Recurrence; Relapse; Resistance; Retrieval; Role; Signal Transduction; Site; Somatostatin; Stimulus; Stress; Symptoms; Synapses; Syndrome; System; Testing; Time; Training; Transgenic Mice; Trauma; alpha-1 adrenergic receptors; attenuation; base; brain pathway; cell type; conditioned fear; designer receptors exclusively activated by designer drugs; emotional experience; experience; experimental study; fear memory; flexibility; gamma-Aminobutyric Acid; improved; in vivo; inhibitory neuron; knock-down; noradrenergic; novel; optogenetics; patch clamp; preclinical study; public health relevance; receptor; response; service member; success; transmission process; traumatic event

DESCRIPTION (provided by applicant): Learning reorganizes brain activity to encode long-lasting memories of emotional events. These memories enhance survival by guiding adaptive behaviors like pursuit of food and avoidance of threats. However, in 6.8% of Americans, and as high as 14-16% of U.S. military service members, the experience of trauma leads to severe and recurrent anxiety and fear, exacerbated by reminders of the traumatic event. This syndrome, known as post-traumatic stress disorder (PTSD), shares commonalities with fear-related disorders like panic and phobia, and is characterized by persistent re-experiencing of traumatic emotion. Current treatments for PTSD confer some remission of symptoms, but do not work in some individuals, and frequently become ineffective over time due to relapse. Acquisition and attenuation of emotional responses can be modeled in the laboratory by Pavlovian fear conditioning and extinction. These studies have suggested that one factor impeding recovery from PTSD may be exposure to stress-related neurotransmitters. The goal of this study is to define which cells and brain pathways mediate adverse effects of the neurotransmitter noradrenaline. In preliminary experiments, we determined that noradrenaline signals through the a1 adrenoreceptor subtype to activate inhibitory neurons and increase their transmission in the amygdala, a critical brain region in fear conditioning and a site of abnormal activity in PTSD. Furthermore, we show that these receptors promote formation of fear memories that are resistant to extinction, a process for inhibiting fear that is analogous to exposure-based emotional therapies. The objective of this proposal is to define the specific circuit mechanisms that, when activated by noradrenaline, impede extinction. Our specific aims are 1. To establish the role of specific inhibitory cell types in noradrenaline-dependent circuit modifications, 2. To test the impact of these inhibitory neurons on behavioral flexibility, and 3. To establish circuit determinants of extinction success and failure. We will rely on transgenic mice, patch-clamp electrophysiology, optogenetics and chemicogenetics to accomplish these goals. The results of these experiments will define cell types as well as synaptic pathways at which improved therapies for attenuating emotion can be directed.

描述（由申请人提供）：学习重组大脑活动，以编码情感事件的持久记忆。这些记忆通过引导适应性行为，如追求食物和避免威胁，来提高生存能力。然而，在6.8%的美国人中，以及高达14-16%的美国军人中，创伤经历会导致严重和反复出现的焦虑和恐惧，而对创伤事件的回忆又会加剧这种焦虑和恐惧。这种综合症被称为创伤后应激障碍（PTSD），与恐慌和恐惧症等与恐惧相关的疾病有共同之处，其特征是持续地重新体验创伤情绪。目前对PTSD的治疗可以缓解一些症状，但对某些个体不起作用，而且由于复发，随着时间的推移往往变得无效。情绪反应的获得和衰减可以在实验室中通过巴甫洛夫恐惧条件反射和消退来模拟。这些研究表明，阻碍PTSD恢复的一个因素可能是暴露于与压力相关的神经递质。本研究的目的是确定哪些细胞和脑通路介导神经递质去甲肾上腺素的不良影响。在初步实验中，我们确定去甲肾上腺素信号通过a1肾上腺素受体亚型激活抑制性神经元，并增加其在杏仁核中的传递，杏仁核是恐惧调节的关键大脑区域，也是创伤后应激障碍的异常活动部位。